Type 1 diabetes mellitus caused by treatment with interferon-β

被引:17
|
作者
Kado, S [1 ]
Miyamoto, J [1 ]
Komatsu, N [1 ]
Iwaki, Y [1 ]
Ozaki, H [1 ]
Taguchi, H [1 ]
Kure, M [1 ]
Sarashina, G [1 ]
Watanabe, T [1 ]
Katsura, Y [1 ]
Nemoto, Y [1 ]
Noritake, M [1 ]
Matsuoka, T [1 ]
机构
[1] Tokyo Med Univ, Dept Internal Med 5, Inashiki, Ibaragi 3000395, Japan
关键词
GAD antibody; chronic hepatitis; hepatitis C virus; human leukocyte antigen;
D O I
10.2169/internalmedicine.39.146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 57-year-old man was referred to our outpatient clinic after interferon-beta (IFN-beta) treatment for 7 weeks. While IFN-beta therapy was continued in our outpatient clinic, his blood glucose level increased gradually, and he was admitted to our hospital for hyperglycemia. The patient was prescribed a 1,600-kcal diet and intensive insulin therapy was performed. GAD antibody became positive 15 months after the start of IFN therapy, and disappeared 27 months after the start of IFN therapy. Insulin secretion was depleted and the patient had HLA-DR4, B54, and DRB1*0405, This appears to be a case of type 1 diabetes mellitus induced by administration of IFN-beta alone.
引用
收藏
页码:146 / 149
页数:4
相关论文
共 50 条
  • [41] Interferon-γ responses to Mycobacterium tuberculosis-specific antigens in diabetes mellitus
    Gan, Suay-Hong
    KhinMar, Kyi-Win
    Barkham, Timothy M.
    Koh, Chwee-Kim
    Shen, Liang
    Wang, Yee-Tang
    Chee, Cynthia B. E.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (03) : 805 - 808
  • [42] Alendronate treatment in type 1 diabetes mellitus patients
    Vartman, K
    Ametov, A
    BONE, 2002, 30 (03) : 54S - 54S
  • [43] STEM CELL TREATMENT FOR TYPE 1 DIABETES MELLITUS
    Qadeer, Faiqa
    Riaz, Saber
    Liaqat, Mukhtar
    Aslam, Kashif
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (08): : 7691 - 7702
  • [44] Insulin pump treatment in type 1 diabetes mellitus
    Klinkert, C
    Quester, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (20) : 1149 - 1154
  • [45] Recent advances in the treatment of type 1 diabetes mellitus
    Schloot, N. C.
    Roden, M.
    Bornstein, S. R.
    Brendel, M. D.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (05) : 172 - 175
  • [46] New developments in the treatment of type 1 diabetes mellitus
    Haak, T
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 : S108 - S113
  • [47] Treatment of cataract in children with type 1 diabetes mellitus
    Zaydullin, I. S.
    Aznabaev, R. A.
    Nurmukhametova, D. S.
    DIABETES MELLITUS, 2006, 9 (03): : 32 - 33
  • [48] Metformin in type 1 diabetes mellitus? Revisiting treatment dogmas in diabetes
    Klupa, Tomasz
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2016, 126 (7-8): : 461 - 462
  • [49] Interferon-β treatment of patients with enterovirus caused left ventricular dysfunction
    Kuehl, U
    Pauschinger, M
    Schimmbeck, PL
    Seeberg, B
    Schultheiss, HP
    CIRCULATION, 2000, 102 (18) : 788 - 788
  • [50] INTERFERON-ALFA AND DEVELOPMENT OF TYPE-1 DIABETES-MELLITUS
    KOIVISTO, VA
    LANCET, 1992, 340 (8829): : 1236 - 1236